BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4896110)

  • 1. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.
    Lewis MG; Ikonopisov RL; Nairn RC; Phillips TM; Fairley GH; Bodenham DC; Alexander P
    Br Med J; 1969 Sep; 3(5670):547-52. PubMed ID: 4896110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunization with irradiated tumour cells in human malignant melanoma.
    Ikonopisov RL; Lewis MG; Hunter-Craig ID; Bodenham DC; Phillips TM; Cooling CI; Proctor J; Fairley GH; Alexander P
    Br Med J; 1970 Jun; 2(5712):752-4. PubMed ID: 4913783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
    Currie GA; Lejeune F; Fairley GH
    Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological studies in patients with malignant melanoma of the uvea.
    Brownstein S; Sheikh KM; Lewis MG
    Can J Ophthalmol; 1977 Jan; 12(1):16-23. PubMed ID: 849536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma.
    Thomas PJ; Kaur JS; Aitcheson CT; Robinson WA; Tan EM
    Cancer Res; 1983 Mar; 43(3):1372-80. PubMed ID: 6337706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating antibodies in malignant melanoma patients.
    Betterle C; Peserico A; Bersani G; Ninfo V; Del Prete GF; Stefani R; Nitti D
    Dermatologica; 1979; 159(1):24-9. PubMed ID: 383530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of tumor specific immune reactions in human melanoma.
    Fairley GH; Lewis MG; Ikonopisov RL; Nairn RC; Alexander P
    Ann N Y Acad Sci; 1971 Jun; 177():286-9. PubMed ID: 4945666
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of human malignant melanoma antigens by immunofluorescence and autologous postimmune antimelanoma sera.
    Leong SP
    Ann N Y Acad Sci; 1983; 420():237-50. PubMed ID: 6372592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune reactions in uveal melanoma.
    Rahi AH
    Br J Ophthalmol; 1971 Dec; 55(12):793-807. PubMed ID: 4946074
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera. Lack of tumor-specific reactions on melanoma lines.
    The TH; Huiges HA; Schraffordt Koops H; Lamberts HB; Nieweg HO
    Ann N Y Acad Sci; 1975 Jun; 254():528-40. PubMed ID: 1101782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against beta-cell surface or cytoplasmic antigens.
    Houssaint E; Pogu S; Ouary M; Sai P
    Clin Exp Immunol; 1990 Oct; 82(1):44-51. PubMed ID: 1698582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
    Ferrone S; Pellegrino MA
    J Natl Cancer Inst; 1977 May; 58(5):1201-4. PubMed ID: 67208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics.
    Shiku H; Takahashi T; Resnick LA; Oettgen HF; Old LJ
    J Exp Med; 1977 Mar; 145(3):784-9. PubMed ID: 233917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies and antigen expression in human melanoma detected by the immune adherence test.
    Cornain S; de Vries JE; Collard J; Vennegoor C; van Wingerden I; Rümke P
    Int J Cancer; 1975 Dec; 16(6):981-97. PubMed ID: 1104492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different fixatives on the localization of human melanoma antigens by immunofluorescence.
    Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET
    Oncology; 1979; 36(5):202-7. PubMed ID: 384307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.
    Milam AH; Saari JC; Jacobson SG; Lubinski WP; Feun LG; Alexander KR
    Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):91-100. PubMed ID: 8425845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.